Dysbindin domain-containing protein 2 variant DBNDD2:34 that was upregulated in BRCA1 mutated breast cancer [63] was found downregulated in the AKT1 silenced sample compared to control (siNoN). This evidence concerns the gene DBNDD2 and breast carcinoma.